Capsular contracture is not life-threatening in most cases, but it can cause significant pain, distort the shape of the breast, and in rare situations signal a more serious condition. It develops when the natural scar tissue your body forms around a breast implant tightens and hardens beyond what’s normal. The severity ranges from barely noticeable to intensely painful, and the level of danger depends almost entirely on how far it progresses and whether it’s addressed.
What Happens Inside the Breast
Every breast implant triggers a foreign body reaction. Within minutes of placement, your immune system begins building a thin capsule of scar tissue around the implant. This is normal and expected. In most people, that capsule stays soft and flexible, and you’d never know it was there.
Problems start when something keeps the inflammation going instead of letting it resolve. Bacterial contamination on the implant surface (called biofilm), tiny particles shed by silicone implants, or ongoing movement of the implant against tissue can all keep immune cells in an aggressive, inflammatory state. When that happens, the scar tissue thickens and contracts, squeezing the implant like a fist closing around a ball. The result is a breast that feels hard, looks misshapen, and often hurts.
How Severity Is Graded
Surgeons use four grades to describe capsular contracture, and the risk to you changes dramatically across them:
- Grade I: The breast looks and feels normal. The capsule is there but causes no symptoms.
- Grade II: The breast feels slightly firm but still looks normal. Most people aren’t bothered at this stage.
- Grade III: The breast feels hard and visibly appears distorted. Pain is common.
- Grade IV: The breast is hard, painful, distorted, and often tender to the touch. This is the stage where surgical intervention is typically necessary.
Grades I and II are generally not dangerous and may never require treatment. Grades III and IV are where real problems begin: chronic pain, limited comfort during physical activity, and visible deformity that affects quality of life.
How Common It Is
Reported rates vary widely depending on the type of surgery and how long patients are followed. Published incidence ranges from about 2.3% to 39% of implant-based procedures. In one national registry study of breast reconstruction patients, severe contracture requiring surgery occurred in 3.6% of implants over a median follow-up period. The cumulative incidence climbed gradually: 1.9% at one year, 3.4% at two years, and 4.7% after five years.
About 75% of all capsular contractures appear within the first two years after implant placement. Late-onset contracture does happen, but it’s less common and often points to an implant rupture as the underlying cause.
The Link to Implant Rupture
Capsular contracture and implant rupture have a strong, bidirectional relationship. A study comparing breasts with ruptured implants to intact implants within the same patients found that 50% of breasts with ruptured implants had contracture, compared to 24% on the intact side. For standard-cohesion silicone implants, a ruptured implant carried roughly 7.5 times the odds of developing contracture.
The reason is straightforward: when an implant ruptures, silicone leaks into the surrounding capsule. Capsules around ruptured implants contained a median of about 2 mL of silicone versus just 0.1 mL around intact ones. That leaked silicone triggers a fresh wave of inflammation, thickening the capsule and accelerating fibrosis. This is one of the more serious complications of untreated contracture, because a tightening capsule can place enough mechanical pressure on the implant to contribute to rupture, which then makes the contracture worse.
The Rare but Serious Cancer Connection
The most alarming risk associated with breast implants is Breast Implant-Associated Anaplastic Large Cell Lymphoma, or BIA-ALCL. This is a rare type of immune system cancer, not breast cancer, that develops in the tissue surrounding the implant. It’s most strongly linked to textured implants, and awareness of this connection has led to a significant reduction in textured implant use.
Capsular contracture is listed as a less common presenting sign of BIA-ALCL. The more typical warning signs are a sudden, unexplained swelling of the breast (from fluid accumulation around the implant) or a palpable mass, which is present in 17% to 31% of diagnosed cases. Some patients also develop skin changes, swollen lymph nodes, or systemic symptoms like fever, night sweats, and unexplained weight loss. Late-onset contracture, especially when it develops years after surgery and can’t be explained by rupture, warrants evaluation to rule out BIA-ALCL.
What Treatment Looks Like
For early or mild contracture (Grades I and II), some patients respond to anti-inflammatory medications. A class of drugs originally designed for asthma has shown promise in reducing contracture by blocking the inflammatory molecules that drive scar tissue formation. A systematic review found that one of these medications reduced the risk of contracture by about 40% compared to controls. These medications work best for prevention or early-stage treatment, not for reversing severe, established contracture.
For Grades III and IV, surgery is the standard approach. The two main options are capsulotomy (scoring or releasing the scar tissue) and capsulectomy (removing the entire capsule). In a large analysis of over 2,200 capsulectomy patients, the overall complication rate was 3.0%, with major complications occurring in about 2.2% of cases. The reoperation and readmission rate was 2.0%. Most patients went home the same day, though about 6% required a hospital stay beyond one night.
The biggest frustration with surgical treatment is recurrence. Reported rates after capsulectomy range from 0% to 46%, and rates after capsulotomy are even wider, from 0% to 54%. This wide range reflects different surgical techniques, implant types, and follow-up periods across studies, but the bottom line is that contracture can come back after surgery, sometimes more than once.
When Contracture Becomes a Real Concern
Capsular contracture is not dangerous in the way a heart attack or an aggressive cancer is dangerous. At lower grades, it’s a cosmetic nuisance. At higher grades, it becomes a source of chronic pain and ongoing inflammation that degrades quality of life and may require one or more surgeries to resolve. The true dangers are indirect: the association with implant rupture and silicone leakage, the small but real risk of masking or presenting alongside BIA-ALCL, and the physical and emotional toll of repeated corrective surgeries.
Any new hardening, swelling, pain, or shape change in a breast with an implant deserves evaluation, especially if it develops suddenly or years after the original surgery. Late-onset contracture in particular should prompt imaging to check for rupture and, when clinically appropriate, screening for BIA-ALCL.